Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Chinese Medicine Angong Niuhuang Wan for the Treatment of the Stroke: A Randomized, Double-blind,Placebo Controlled Clinical Trial
Conditions
Interventions
Angong Niuhuang Wan
Angong Niuhuang Wan Placebo
Locations
1
Hong Kong
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Start Date
October 15, 2019
Primary Completion Date
December 30, 2022
Completion Date
June 30, 2023
Last Updated
January 29, 2021
NCT07500116
NCT06192953
NCT05885295
NCT05878457
NCT04580238
NCT05319418
Lead Sponsor
Chinese University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions